
-
Reagents
- Flow Cytometry Reagents
-
Western Blotting and Molecular Reagents
- Immunoassay Reagents
-
Single-Cell Multiomics Reagents
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Protein Panels
-
Functional Assays
-
Microscopy and Imaging Reagents
-
Cell Preparation and Separation Reagents
-
Training
- Flow Cytometry Basic Training
-
Product-Based Training
- FACSAria Product Based Training
- FACSMelody Product-Based Training
- FACSLyric Product-Based Training
- FACSCanto Product-Based Training
- LSRFortessa Product-Based Training
- FACSymphony Product-Based Training
- FACSDuet Product-Based Training
- HTS Product-Based Training
- BD FACSDiscover™ S8 Cell Sorter Product Training
-
Advanced Training
-
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Protein Panels
-
- FACSAria Product Based Training
- FACSMelody Product-Based Training
- FACSLyric Product-Based Training
- FACSCanto Product-Based Training
- LSRFortessa Product-Based Training
- FACSymphony Product-Based Training
- FACSDuet Product-Based Training
- HTS Product-Based Training
- BD FACSDiscover™ S8 Cell Sorter Product Training
- Singapore (English)
-
Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
BD Pharmingen™ Human Active Caspase-3 ELISA Pair

ELISA analysis for active caspase-3. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were either left untreated or were treated with 4 µM camptothecin for 4 hr to induce apoptosis. The cell lysates and blank (assay diluent) were added to ELISA plates coated with component 51-69951E as the capture antibody. The lysates were serially diluted 2-fold starting with concentrations of 1 mg/ml. After incubation with the lysates, the plates were washed and then incubated with component 51-68651E as the detection antibody for 2 hr at room temperature followed by detection with a HRP goat anti-rabbit antibody. The results demonstrate that active caspase-3 is dectected in camptothecin treated lysates at a level that is approximately 14-fold greater than that found in the untreated lysates.

Time course of active caspase-3 levels following apoptosis induction. Jurkat cells were left untreated (0 hr) or treated with 4 µM camptothecin to induce apoptosis. The cell lysates were used at a concentration of 1 mg/ml and the assay was performed according to the recommended assay protocol. The results show that the level of active caspase-3 increased progressively between 0 and 3 hr before reaching a plateau.

Analysis of active caspase-3 in Jurkat and MCF-7 cells. MCF-7 and Jurkat cell lines were left untreated or treated with staurosporine (4 µM, 18 hr). The cell lysates (1 mg/ml) were added to ELISA plates coated with Capture Antibody. Following incubation and washing, the Detection Antibody was added and the assay was performed according to the recommended assay protocol. The results demonstrate that active caspase-3 in staurosporine treated MCF-7 cells was not significantly different than untreated cells indicating a lack of detectable activity in these cells. In contrast, active caspase-3 was detected in staurosporine treated Jurkat cells at a level that was ~10-fold higher in this experiment compared to that of the untreated Jurkat lysate. MCF-7 is a breast cancer cell line that does not express caspase-3 due to a 47-base pair deletion within exon 3 of the caspase-3 gene. Assay Diluent was used as a blank.




ELISA analysis for active caspase-3. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were either left untreated or were treated with 4 µM camptothecin for 4 hr to induce apoptosis. The cell lysates and blank (assay diluent) were added to ELISA plates coated with component 51-69951E as the capture antibody. The lysates were serially diluted 2-fold starting with concentrations of 1 mg/ml. After incubation with the lysates, the plates were washed and then incubated with component 51-68651E as the detection antibody for 2 hr at room temperature followed by detection with a HRP goat anti-rabbit antibody. The results demonstrate that active caspase-3 is dectected in camptothecin treated lysates at a level that is approximately 14-fold greater than that found in the untreated lysates.
Time course of active caspase-3 levels following apoptosis induction. Jurkat cells were left untreated (0 hr) or treated with 4 µM camptothecin to induce apoptosis. The cell lysates were used at a concentration of 1 mg/ml and the assay was performed according to the recommended assay protocol. The results show that the level of active caspase-3 increased progressively between 0 and 3 hr before reaching a plateau.
Analysis of active caspase-3 in Jurkat and MCF-7 cells. MCF-7 and Jurkat cell lines were left untreated or treated with staurosporine (4 µM, 18 hr). The cell lysates (1 mg/ml) were added to ELISA plates coated with Capture Antibody. Following incubation and washing, the Detection Antibody was added and the assay was performed according to the recommended assay protocol. The results demonstrate that active caspase-3 in staurosporine treated MCF-7 cells was not significantly different than untreated cells indicating a lack of detectable activity in these cells. In contrast, active caspase-3 was detected in staurosporine treated Jurkat cells at a level that was ~10-fold higher in this experiment compared to that of the untreated Jurkat lysate. MCF-7 is a breast cancer cell line that does not express caspase-3 due to a 47-base pair deletion within exon 3 of the caspase-3 gene. Assay Diluent was used as a blank.

ELISA analysis for active caspase-3. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were either left untreated or were treated with 4 µM camptothecin for 4 hr to induce apoptosis. The cell lysates and blank (assay diluent) were added to ELISA plates coated with component 51-69951E as the capture antibody. The lysates were serially diluted 2-fold starting with concentrations of 1 mg/ml. After incubation with the lysates, the plates were washed and then incubated with component 51-68651E as the detection antibody for 2 hr at room temperature followed by detection with a HRP goat anti-rabbit antibody. The results demonstrate that active caspase-3 is dectected in camptothecin treated lysates at a level that is approximately 14-fold greater than that found in the untreated lysates.

Time course of active caspase-3 levels following apoptosis induction. Jurkat cells were left untreated (0 hr) or treated with 4 µM camptothecin to induce apoptosis. The cell lysates were used at a concentration of 1 mg/ml and the assay was performed according to the recommended assay protocol. The results show that the level of active caspase-3 increased progressively between 0 and 3 hr before reaching a plateau.

Analysis of active caspase-3 in Jurkat and MCF-7 cells. MCF-7 and Jurkat cell lines were left untreated or treated with staurosporine (4 µM, 18 hr). The cell lysates (1 mg/ml) were added to ELISA plates coated with Capture Antibody. Following incubation and washing, the Detection Antibody was added and the assay was performed according to the recommended assay protocol. The results demonstrate that active caspase-3 in staurosporine treated MCF-7 cells was not significantly different than untreated cells indicating a lack of detectable activity in these cells. In contrast, active caspase-3 was detected in staurosporine treated Jurkat cells at a level that was ~10-fold higher in this experiment compared to that of the untreated Jurkat lysate. MCF-7 is a breast cancer cell line that does not express caspase-3 due to a 47-base pair deletion within exon 3 of the caspase-3 gene. Assay Diluent was used as a blank.


BD Pharmingen™ Human Active Caspase-3 ELISA Pair

BD Pharmingen™ Human Active Caspase-3 ELISA Pair

BD Pharmingen™ Human Active Caspase-3 ELISA Pair

Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Description
The caspase family of cysteine proteases plays a key role in apoptosis and inflammation. Caspase-3 (CPP32, Yama, apopain) is a key protease that is activated during the early stages of apoptosis and, like other members of the caspase family, is synthesized as an inactive proenzyme that is processed in cells undergoing apoptosis by self-proteolysis and/or cleavage by another protease. The processed forms of caspases consist of large (17-22 kDa) and small (10-12 kDa) subunits which associate to form an active enzyme. Active caspase-3, a marker for cells undergoing apoptosis, consists of a heterodimer of 12 and 17 kDa subunits, which is derived from the 32 kDa proenzyme. Active caspase-3 proteolytically cleaves and activates other caspases, as well as relevant targets in the cytoplasm (e.g D4-GDI and Bcl-2) and in the nucleus (e.g. PARP). The mouse anti-human caspase-3 antibody (clone 19) recognizes both the pro- and active forms of human caspase-3 and reportedly does not detect mouse caspase-3. The rabbit anti-active caspase-3 detection antibody (clone C92-605) recognizes the active form of human and mouse caspase-3.
Both antibodies are supplied in enough quantity for investigators to perform the ELISA in 10 standard 96-well microtiter plates.
Preparation And Storage
Recommended Assay Procedures
Induction of Apoptosis
Apoptosis may be induced in response to various cytotoxic stimuli including activation of cell surface receptors such as Fas, TNFR1, TCR, serum or growth factor withdrawl, UV irradiation, various chemicals, glucocorticoid or calcium ionophore treatment, and CTL-targeting of virally or tumor transformed cells. There are numerous methods for induction of apoptosis in vitro and each investigator is encouraged to optimize protocols for their own experimental system. A protocol for induction of apoptosis using camptothecin (a potent inhibitor of topoisomerase I) or staurosporine (a protein kinase inhibitor) is provided in this section.
Preparation of an Apoptotic Jurkat ELISA Standard from Cell Culture
1. Prepare 1.0 mM stock solution of camptothecin (Sigma; Cat. No. C-9911) or staurosporine (Sigma Cat. No. S-4400) in 1.0 mM DMSO.
2 . Add camptothecin (final concentration of 4 -6 µM ) or staurosporine (final concentration of 1-4 µM ) to the cell suspension e.g., 1 x10^6 cells/mL in tissue culture medium.
3. Incubate the cells for 2-18 hr in staurosporine or 4-6 hr in camptothecin at 37°C.
4. After incubation, collect cells and wash with 1X PBS.
5. Prior to use in ELISA, investigators may want to independently confirm that the cells have undergone apoptosis. Please refer to the general scientific literature for methodology.
6. Lyse cells with Cell Lysis Buffer (Cat. No. 559759) for 30 min on ice, vortexing every 5 min. Collect lysate by centrifugation.
7. Determine protein concentration and dilute with Assay Diluent so that the final concentration of the lysate should be at 1 mg/ml. Ideally, fresh lysates should be used for each assay, but the lysates may be aliquoted and stored at -80°C for up to one week.
Reagents Provided
1. Capture Antibody (0.5 ml): Purified Mouse Anti-Human Caspase-3 Antibody (clone 19). For one 96-well plate, add 50 µl Ab to 11.95 ml Coating Buffer. The total volume needed for a 96-well ELISA plate is 9.6 ml, but preparation for a total volume of 12 ml is recommended.
2. Detection Antibody (0.5 ml): Purified Rabbit Anti-Active Caspase-3 Antibody (clone C92-605). For one 96-well plate, add 50 µl Ab to 11.95 ml Assay Diluent. The total volume needed for a 96-well ELISA plate is 9.6 ml, but preparation for a total volume of 12 ml is recommended.
Reagents Not Provided
Note: Do not use sodium azide in these preparations as it will inhibit/inactivate horseradish peroxidase enzyme activity.
1. Enzyme Reagent: HRP Goat Anti-Rabbit Antibody (Cat. No. 554021).
2. Standards: Investigators are encouraged to prepare their own apoptotic lysates.
3. Cell Lysis Buffer (Cat. No. 559759).
4. Coating Buffer: 0.1 M NaHCO3 (pH 9.5). Prepare fresh and use within 7 days of preparation. Store at 2-8°C.
5. Assay Diluent (Cat. No. 555213): Store at 2-8°C.
6. Wash Buffer: Phosphate-Buffered Saline (80.0 g NaCl, 11.6 g Na2HPO4, 2.0 g KH2PO4, 2.0 g KCl, q.s. to 10 L; pH to 7.0) with 0.05% (w/v) Tween-20. Prepare fresh and use within 3 days of preparation. Store at 2-8°C.
7. TMB Substrate Reagent Set (Cat. No. 555214): contains Tetramethylbenzidine (TMB) and hydrogen peroxide.
8. Stop Solution: 1 M H3PO4 or 2 N H2SO4.
9. ELISA/Microtiter plates: BD Falcon™ (Cat. No. 353279) or NUNC Maxisorp (Cat. No. 442404) 96-well plates are suggested.
10. Microplate reader capable of measuring absorbance at 450 nm.
ELISA Assay Protocol
1. Add 100 µl of the mouse anti-human caspase-3 (clone 19) (capture antibody), diluted in Coating Buffer, to each ELISA/microtiter plate well. For one 96-well plate, add 50 µl antibody to 11.95 ml Coating Buffer.
2. Seal plate and incubate overnight at 4° C.
3. Aspirate wells and wash 3 times with ~300 µl/well of Wash Buffer. After last wash, invert plate and blot on absorbent paper to remove any residual buffer.
4. Block plates with ~200 µl/well of Assay Diluent. Incubate at room temperature for 1 hr.
5. Aspirate/wash as in Step 2.
6. Prepare standard and sample dilutions in Assay Diluent.
7. Pipette 100 µl of the standard, sample lysate, and blank (Assay Diluent alone) into appropriate wells. Seal plate and incubate for 2 hr at room temperature.
8. Aspirate/wash as in Step 2, but with 5 total washes.
9. Add 100 µl of rabbit anti-active caspase-3 (clone C92-605) (detection antibody), diluted in Assay Diluent, to each ELISA/microtiter well. For one 96-well plate, add 50 µl antibody to 11.95 ml Assay Diluent.
10. Seal plate and incubate for 1 hr at room temperature.
11. Aspirate/wash as in Step 2, but with 5 total washes.
12. Add 100 µl of HRP Goat Anti-Rabbit antibody (Cat. No. 554021), diluted in Assay Diluent, to each ELISA/microtiter well. For one 96-well plate, add 2.4 µl of antibody to 11.95 ml Assay Diluent.
13. Incubate for 1 hr at room temperature.
14. Aspirate/wash as in Step 2, but with 7 total washes.
15. Add 100 µl of TMB Substrate Solution to each well. Incubate plate, without the plate sealer, for 30 min at room temperature in the dark.
16. Add 50 µl of Stop Solution to each well.
17. Read absorbance at 450 nm within 30 minutes of stopping reaction. If wavelength correction is available, subtract the absorbance at 570 nm from the absorbance at 450 nm.
Product Notices
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- Source of all serum proteins is from USDA inspected abattoirs located in the United States.
Data Sheets
Companion Products




Description | Quantity/Size | Part Number | EntrezGene ID |
---|---|---|---|
Purified Mouse Anti-Human Caspase-3 | 0.5 mL (1 ea) | 51-69951E | N/A |
Purified Rabbit Anti-Active Caspase-3 | 0.5 mL (1 ea) | 51-68651E | N/A |
Development References (4)
-
Dai C, Krantz SB. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood. 1999; 93(10):3309-3316. (Biology). View Reference
-
Fujita N, Tsuruo T. Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem Biophys Res Commun. 1998; 246(2):484-488. (Biology). View Reference
-
Jänicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 1998; 273(16):9357-9360. (Methodology). View Reference
-
Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998; 281(5381):1312-1316. (Biology). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.